TIAA Trust National Association Purchases 1,605 Shares of Waters Corporation $WAT

TIAA Trust National Association raised its position in Waters Corporation (NYSE:WAT) by 161.6% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 2,598 shares of the medical instruments supplier’s stock after buying an additional 1,605 shares during the period. TIAA Trust National Association’s holdings in Waters were worth $907,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Swedbank AB raised its stake in Waters by 25.8% during the 2nd quarter. Swedbank AB now owns 40,526 shares of the medical instruments supplier’s stock worth $14,145,000 after buying an additional 8,305 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in Waters by 5.6% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 530,697 shares of the medical instruments supplier’s stock worth $195,599,000 after buying an additional 28,018 shares during the period. Jacobs Levy Equity Management Inc. acquired a new stake in Waters during the 1st quarter worth $1,244,000. Mn Services Vermogensbeheer B.V. raised its stake in Waters by 7.0% during the 2nd quarter. Mn Services Vermogensbeheer B.V. now owns 22,933 shares of the medical instruments supplier’s stock worth $8,005,000 after buying an additional 1,500 shares during the period. Finally, Mirae Asset Global Investments Co. Ltd. raised its stake in Waters by 12.6% during the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 8,021 shares of the medical instruments supplier’s stock worth $2,800,000 after buying an additional 896 shares during the period. 94.01% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several analysts recently commented on the company. Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the stock a “hold” rating in a research note on Tuesday, August 5th. Wells Fargo & Company dropped their price target on Waters from $330.00 to $315.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 5th. Jefferies Financial Group set a $385.00 price target on Waters and gave the company a “buy” rating in a research note on Monday, August 4th. Redburn Partners set a $390.00 price target on Waters in a research note on Wednesday, October 8th. Finally, UBS Group reissued a “neutral” rating on shares of Waters in a research note on Tuesday, July 15th. Two analysts have rated the stock with a Strong Buy rating, six have given a Buy rating and seven have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $375.54.

Waters Price Performance

Shares of NYSE WAT opened at $368.41 on Wednesday. The stock has a market capitalization of $21.93 billion, a price-to-earnings ratio of 33.22, a PEG ratio of 3.19 and a beta of 1.04. The business has a 50-day moving average of $319.11 and a 200-day moving average of $325.09. The company has a debt-to-equity ratio of 0.55, a current ratio of 1.75 and a quick ratio of 1.22. Waters Corporation has a fifty-two week low of $275.05 and a fifty-two week high of $423.56.

Waters (NYSE:WAT) last announced its quarterly earnings data on Thursday, May 19th. The medical instruments supplier reported $2.29 earnings per share for the quarter. The company had revenue of $608.55 million during the quarter. Waters had a return on equity of 38.60% and a net margin of 21.71%. As a group, sell-side analysts predict that Waters Corporation will post 12.86 earnings per share for the current fiscal year.

About Waters

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.